Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...

Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...

Please provide your email address to receive an email when new articles are posted on . In a recent study by Tanimoto and colleagues, neffy produced pharmacodynamic results that were comparable with ...

Please provide your email address to receive an email when new articles are posted on . The recommendation was based on data from more than 700 study participants. European Commission authorization is ...

EURneffy offers adults and children (≥30 kg) in Europe living with severe allergic reactions the first new delivery method for adrenaline in more than 30 years in the EU European Commission decision ...

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...